These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22022146)

  • 1. Plasma asymmetric dimethylarginine and L-arginine levels in Chinese patients with essential hypertension without coronary artery disease.
    Wang H; Liu J
    J Cardiovasc Dis Res; 2011 Jul; 2(3):177-80. PubMed ID: 22022146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
    Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
    Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine.
    Cziráki A; Ajtay Z; Németh Á; Lenkey Z; Sulyok E; Szabados S; Alotti N; Martens-Lobenhoffer J; Szabó C; Bode-Böger SM
    Coron Artery Dis; 2011 Jun; 22(4):245-52. PubMed ID: 21383621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine and coronary collateral vessel development.
    Kocaman SA; Sahinarslan A; Biberoglu G; Hasanoglu A; Akyel A; Timurkaynak T; Cengel A
    Coron Artery Dis; 2008 Nov; 19(7):469-74. PubMed ID: 18923242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
    Selçuk MT; Selçuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Duru E; Saşmaz A
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):150-5. PubMed ID: 18626206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertension.
    Poręba R; Gać P; Poręba M; Derkacz A; Chachaj A; Mazur G; Szuba A
    Arch Med Sci; 2015 Jun; 11(3):521-9. PubMed ID: 26170844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
    Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
    YOU L; ZHAO CX; SHAO JM; ZHANG L; WANG DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):798-800. PubMed ID: 21092647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
    Koc F; Ardic I; Erdem S; Kalay N; Ozbek K; Yarlioglues M; Ceyhan K; Celik A; Kadi H; Taner A; Sahin S; Onalan O; Kaya MG
    Coron Artery Dis; 2010 Dec; 21(8):445-9. PubMed ID: 20861735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between brachial-ankle pulse wave velocity and the ratio of l-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography.
    Masaki N; Hakuno D; Toya T; Shiraishi Y; Kujiraoka T; Namba T; Yada H; Kimura K; Miyazaki K; Adachi T
    J Cardiol; 2015 Apr; 65(4):311-7. PubMed ID: 25043133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
    Mokhtari Z; Hosseini S; Miri R; Baghestani AR; Zahedirad M; Rismanchi M; Nasrollahzadeh J
    J Hum Nutr Diet; 2015 Aug; 28(4):350-6. PubMed ID: 25786774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
    Nemeth Z; Cziraki A; Szabados S; Biri B; Keki S; Koller A
    PLoS One; 2015; 10(8):e0135498. PubMed ID: 26313940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
    Wang D; Strandgaard S; Iversen J; Wilcox CS
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
    Päivä H; Laakso J; Laine H; Laaksonen R; Knuuti J; Raitakari OT
    J Am Coll Cardiol; 2002 Oct; 40(7):1241-7. PubMed ID: 12383571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.